Polymorphisms in RANTES have been associated with a higher risk of pancreatic cancer, supporting the hypothesis that proinflammatory gene polymorphisms, in combination with proinflammatory conditions, may influence the development of pancreatic cancer [33]. Here, CCL5 is linked to familial pancreatic carcinoma.